Overall hemostasis potential and aPTT-clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype
- PMID: 32964648
- DOI: 10.1111/ijlh.13347
Overall hemostasis potential and aPTT-clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype
Abstract
Introduction: Traditionally used laboratory methods do not always accurately reflect bleeding severity in hemophilia A (HA) patients. The ability of three global assays for identifying patients with unexpected bleeding phenotype was investigated.
Methods: Overall hemostasis potential (OHP), aPTT-clot waveform analysis (aPTT-CWA), endogenous thrombin potential (ETP), FVIII activities, and prothrombin fragment 1 + 2 concentrations were measured in 62 HA patients (30 severe and 32 non-severe) and 27 male controls. Bleeding phenotype was determined using our proposed scoring system including age at first joint bleed, number of target joints, and number of joint/muscle bleeds per year. Bleeding score ≤ 4 defined patients with mild bleeding phenotype (N = 27); score ≥ 5 defined severe bleeding phenotype (N = 35).
Results: The receiver operating characteristic analysis performed for distinguishing patients with severe and mild bleeding phenotype yielded following values of area under the curve: 0.910 (FVIII); 0.891 (aPTT-CWA parameter DELTA); 0.769 (OHP); and 0.634 (ETP). Unexpected bleeding phenotype was identified in 11/62 HA patients: 8/32 (25%) non-severe HA patients had severe, while 3/30 (10%) severe HA patients had mild bleeding phenotype, and global assays enabled the identification of all these patients. OHP and DELTA were revealed as the most reliable parameters for bleeding phenotype determination (10/11 and 9/11 unexpected results, respectively).
Conclusion: This study emphasizes OHP and aPTT-CWA as a powerful laboratory diagnostic tool in identifying HA patients with unexpected bleeding presentations, with the best results achieved by combining both assays. Global assays should not completely replace FVIII activity measurement but should be a part of the HA diagnostic algorithm.
Keywords: aPTT-clot waveform analysis; bleeding phenotype; endogenous thrombin potential; hemophilia A; overall hemostasis potential.
© 2020 John Wiley & Sons Ltd.
Similar articles
-
Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.Indian J Pathol Microbiol. 2021 Jan-Mar;64(1):117-122. doi: 10.4103/IJPM.IJPM_336_19. Indian J Pathol Microbiol. 2021. PMID: 33433420
-
New quantitative aPTT waveform analysis and its application in laboratory management of haemophilia A patients.Haemophilia. 2014 Nov;20(6):898-904. doi: 10.1111/hae.12492. Epub 2014 Oct 2. Haemophilia. 2014. PMID: 25273337
-
Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab.J Thromb Haemost. 2018 Jun;16(6):1078-1088. doi: 10.1111/jth.14022. Epub 2018 May 13. J Thromb Haemost. 2018. PMID: 29645406
-
Mild hemophilia A.J Thromb Haemost. 2010 Mar;8(3):421-32. doi: 10.1111/j.1538-7836.2009.03717.x. Epub 2009 Dec 7. J Thromb Haemost. 2010. PMID: 19995408 Review.
-
Challenges in the laboratory analyses of bleeding disorders.Thromb Res. 2012 Jul;130(1):1-6. doi: 10.1016/j.thromres.2012.03.011. Epub 2012 Apr 6. Thromb Res. 2012. PMID: 22483776 Review.
Cited by
-
Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy controls.Res Pract Thromb Haemost. 2022 Nov 4;6(7):e12804. doi: 10.1002/rth2.12804. eCollection 2022 Oct. Res Pract Thromb Haemost. 2022. PMID: 36349263 Free PMC article.
-
Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypes.Res Pract Thromb Haemost. 2022 Sep 26;6(6):e12800. doi: 10.1002/rth2.12800. eCollection 2022 Aug. Res Pract Thromb Haemost. 2022. PMID: 36186102 Free PMC article.
-
In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype.Res Pract Thromb Haemost. 2023 Feb 1;7(2):100062. doi: 10.1016/j.rpth.2023.100062. eCollection 2023 Feb. Res Pract Thromb Haemost. 2023. PMID: 36865907 Free PMC article.
-
Advances in laboratory assessment of thrombosis and hemostasis.Blood Res. 2022 Apr 30;57(S1):93-100. doi: 10.5045/br.2022.2022048. Blood Res. 2022. PMID: 35483933 Free PMC article. Review.
References
REFERENCES
-
- White GC II, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Recommendations of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85:560.
-
- Franchini M, Lippi G. Factor V Leiden and hemophilia. Thromb Res. 2010;125:119-123.
-
- Franchini M, Mannucci PM. Modifiers of clinical phenotype in severe congenital hemophilia. Thromb Res. 2017;156:60-64.
-
- Escuriola-Ettingshausen C, Halimeh S, Kurnik K, et al. Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemost. 2001;85:218-220.
-
- Pavlova A, Oldenburg J. Defining severity of hemophilia: more than factor levels. Semin Thromb Hemost. 2013;39:702-710.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical